Search
All
Israeli microbiome company BiomX, which is developing customized phage therapies, has announced that it has entered into a collaboration with Janssen the therapy R&D arm of...
The company, that develops and sells an innovative expense reports software, aims at spurring its international development.
NewAlpha Asset Management announces the acquisition from Seventure Partners and CM-CIC Capital Privé of a majority stake in Presto Engineering, a provider of...
Taking on board learnings from challenges already faced and focusing on advanced, longer-term studies of variables within microbiome research will be key to fostering...
Proceeds to fund Phase 2/3 trial of inhaled TD139 in idiopathic pulmonary fibrosis (IPF) and advancement of oral and ocular pipeline candidates into clinical studies
The company, which was founded in 2016 to develop transformational technology developed at the Sanger Institute, has made rapid progress in developing a unique capability to...
Enterome, a clinical-stage biotech company developing innovative therapies to treat microbiome-associated diseases with a focus on auto-immune disease and cancer, has entered...
LNC aims to develop the first Christensenella-based drug candidate for the treatment of obesity and metabolic disorders
Click to upload our Responsible Investment Report
Vedanta Biosciences, a clinical-stage company developing a new category of therapies for immune-mediated diseases based on rationally defined consortia of human...
